Replies to post #23121 on BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

Thanks Quandonboy

My head was beginning to hurt.

[mcd2inga]

Quandongboy,
So the latest PR is great news even though we have known the following since 2004:

BioCurex to Present its RECAF Blood Test results at International Cancer Congress.
RICHMOND, British Columbia, May 17th 2004. -- BioCurex Inc. (BOCX.PK - News is pleased to announce that the ISOBM 2004 Scientific Committee has reviewed and accepted all five abstracts submitted by Dr. Moro and his scientific team on BioCurex’s patent protected technologies.

The abstracts report the results obtained with BioCurex’s Serum-RECAF(TM) blood test for Ovarian, Breast, Stomach and Lung cancers. Overall, the cancer detection sensitivity reported was in the vicinity of 90% with slightly over 95% specificity. The aggregate number of cancer patients was 175 and normal donors were 353.

The Lung cancer presentation also includes results using the Company’s Histo-RECAF(TM) cancer cell staining kit: Briefly, 22 out of 24 lung cancers were stained positively. Dr. Moro will also present a 5th abstract describing RECAF’s basic scientific background.

The scientific posters will be displayed June 22nd 2004 and the abstracts are to be published in a supplementary issue of the scientific journal “Tumor Biology”.

--------

-But now 5 years later, we are supposed to be excited that Recaf can limit false positives for Ovarian Cancer?

Hopefully you and Half are correct that this PR is just a hint of great things to come in commercializing tests for ovarian and colon cancer using Recaf, but I am skeptical.
mcd

[Gold Seeker]

QD stated: "In fact, large companies like Abbott don't innovate. They sit back and wait for small companies to do the basic science and take an idea far enough towards commercialization that they (i.e., the large companies) can simply step in and license it. IMO that is what the large companies are doing. They are waiting for biocurex to provide enough hard data to satisfy them it will work."

REALLY? So when Abbott licensed RECAF way back in 2005, Moro had done no work on it? Moro showed them that it worked. In November 2004, he released a PR stating that RECAF had 90$ sensitivity and No false positives.

I think Moro did work on RECAF and Abbott attempted to validate that work and the results produced in May of 2006 did not come close to duplicating the results Moro had published in 2004.

If anyone still thinks that Abbott is working on RECAF or working with anyone else on RECAF, they have not done their homework. Abbott has not even paid the feasibility milestone.